Oxford University

Oxford University

Photo: Collected

Oxford University to test Covid-19 vaccine response among children for first time

The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17

Sample from patients are analysed as part of the trial. Photo: BBC.

Oxford scientists preparing vaccine versions to combat emerging virus variants

FILE PHOTO: A 3D-printed coronavirus model is seen in front of a British flag on display in this illustration taken March 25, 2020. REUTERS/Dado Ruvic/Illustration

UK researchers say lateral flow tests detect the most infectious Covid cases

Sample from patients are analysed as part of the trial. Photo: BBC.

Oxford’s vaccine will be ready by christmas, says lead researcher  

FILE PHOTO: People walk past an illustration of a virus outside a regional science centre, as the city and surrounding areas face local restrictions in an effort to avoid a local lockdown being forced upon the region, amid the coronavirus disease (Covid-19) outbreak, in Oldham, Britain August 3, 2020. REUTERS/Phil Noble

Oxford University says Covid-19 patients experience symptoms months after contracting virus

FILE PHOTO: A man walks in front of the buildings of Oxford University, amid the spread of the coronavirus disease (Covid-19) in Oxford, Britain, October 6, 2020. REUTERS/Matthew Childs

Oxford scientists develop five-minute Covid-19 antigen test

Coronavirus may not have originated in China: Oxford University expert

Coronavirus may not have originated in China: Oxford University expert

Malala Yousafzai. Picture: Collected

Malala Yousafzai graduates from Oxford University

A statue of Cecil Rhodes, a controversial historical figure, stands in Oxford, Britain, June 11, 2020/ Reuters

Oxford college says it wants to remove statue of colonialist Rhodes

Photo: Reuters

Covid-19: Oxford university vaccine trials run into complications

Oxford University coronavirus vaccine study moves to next phases of human trials

Oxford University coronavirus vaccine study moves to next phases of human trials